pT1期膀胱尿路上皮癌的病理诊断及分期
被引量:3
摘要
膀胱尿路上皮癌的分期是最重要的预后因子。WHO将浸润性膀胱尿路上皮癌定义为肿瘤侵透基底膜。膀胱癌TNM分期系统(2002)将膀胱的pT1期肿瘤定义为肿瘤浸润固有膜,但未侵及肌层。尽管临床上常将pT1和pTa期(非浸润性肿瘤)合称为“浅表性”膀胱肿瘤,但pT1期肿瘤的预后要比pTa期差,因此正确诊断pT1期肿瘤对于选择治疗方案和估计预后非常重要。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2007年第9期636-639,共4页
Chinese Journal of Pathology
参考文献23
-
1[No author listed]. Lamina propria microinvasion of bladder tumors, incidence on stage allocation ( pTa vs pT1 ): recommended approach. Pathologists of the French Association of Urology Cancer Committee. World J Urol, 1993,11 ( 3 ) : 161-164.
-
2Abel PD, Hall RR, Williams G. Should pT1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol, 1988,62 (3) :235-239.
-
3Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol, 2003, 169 (4) :1291-1294.
-
4Tosoni I, Wagner U, Sauter G, et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int, 2000,85( 1 ) :48-53.
-
5Miladi M, Peyromaure M, Zerbib M, et al. The value of a second transurethral resection in evaluating patients with bladder tumors. Eur Urol, 2003,43 ( 3 ) :241-245.
-
6Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol, 2000,113(2) :275-279.
-
7Reuter VE. Bladder. Risk and prognostic factors-a pathologist's perspective. Urol Clin Nth Am, 1999,26 (3) :481-492.
-
8Farrow GM, Utz DC. Observation on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol, 1982,1 (2) :609- 615.
-
9Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns : a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol, 1997,21(9) :1057-1068.
-
10Lopez-Beltran A, Cheng L, Andersson L, et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch, 2002,440( 1 ) :3-11.
同被引文献39
-
1Cheng L,Lopez-Beltran A,MacLennan GT,et al.Neoplasms of the urinary bladder//Bostwick DG,Cheng L.Urologic surgical pathology.2nd ed.Philadelphia:Elsevier/Mosby,2008:259-352.
-
2Hodges KB,Lopez-Beltran A,Davidson DD,et al.Urothelial dysplasia and other flat lesions of the urinary bladder:clinicopathological and molecular features.Hum Pathol,2010,41(2):155-162.
-
3Cheng L,Zhang S,Davidson DD,et al.Molecular determinants of tumor recurrence in the urinary bladder.Future Oncol,2009,5(6):843-857.
-
4Majewski T,Lee S,Jeong J,et al.Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.Lab Invest,2008,88 (7):694-721.
-
5Requena MJ,Alvarez-Kindelan J,Blanca A.Immunohistochemical markers in the evaluation of tumors of the urinary bladder:a review.Anal Quant Cytol Histol,2007,29(6):380-382.
-
6Cheng L,Cheville JC,Neumann RM,et al.Flat intraepithelial lesions of the urinary bladder.Cancer,2000,88 (3):625-631.
-
7Epstein JI,Amin MB,Reuter VR,et al.The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder.Bladder Consensus Conference Committee.Am J Surg Pathol,1998,22 (12):1435-1448.
-
8Hartmann A,R(o)sner U,Schlake G,et al.Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.Lab Invest,2000,80(5):709-718.
-
9Shirai T,Fukushima S,Hirose M,et al.Epithelial lesions of the urinary bladder in in three hundred and thirteen autopsy cases.Jpn J Cancer Res,1987,78 (10):1073-1080.
-
10Cheng L,Cheville JC,Neumann RM,et al.Natural history of urothelial dysplasia of the bladder.Am J Surg Pathol,1999,23(4):443-447.
引证文献3
-
1程亮,徐嘉雯,滕晓东.尿路上皮平坦型病变临床病理学进展[J].中华病理学杂志,2010,39(9):577-581. 被引量:2
-
2罗静,张进生,王翠芝,刘宁.经尿道电切术治疗的膀胱尿路上皮肿瘤病理特点及与预后相关性研究[J].首都医科大学学报,2012,33(5):656-660. 被引量:5
-
3贺森,梁群英.经尿道电切术治疗的膀胱尿路上皮肿瘤病理特点及与预后相关性研究[J].西藏医药,2015,36(2):22-23.
二级引证文献7
-
1范诗秋,谢文杰,李波,谢光彪,朱瑜.经尿道电切术与开放性手术治疗早期膀胱肿瘤的疗效对比[J].中国老年学杂志,2013,33(20):5176-5177. 被引量:12
-
2闫伟,康雯婷,陈山,刘跃新.荧光原位杂交技术在膀胱尿路上皮癌术后复发的早期检测中的临床应用价值[J].首都医科大学学报,2014,35(3):298-301. 被引量:2
-
3李春浩,朗金田,张志坚,崔刚.早期膀胱肿瘤经尿道电切与开放式手术二种方法比较[J].浙江临床医学,2014,16(10):1634-1635.
-
4赵俊杰,宋瑞祥,张振声,周铁,杨波,曾蜀雄,侯建国,孙颖浩,许传亮.20~30岁膀胱肿瘤患者临床特征分析[J].第二军医大学学报,2015,36(2):216-220. 被引量:3
-
5沈丽.膀胱癌术后灌注化疗的护理体会[J].现代妇女(医学前沿),2015,0(1):150-151.
-
6贺森,梁群英.经尿道电切术治疗的膀胱尿路上皮肿瘤病理特点及与预后相关性研究[J].西藏医药,2015,36(2):22-23.
-
7高飞,王贵荣.丝裂霉素膀胱内热灌注联合经尿道电切术治疗膀胱癌32例[J].中国药业,2015,24(17):85-86. 被引量:8
-
1宋奇思.远离大肠癌的生活方式[J].科学养生,2007(12):20-22.
-
2王金鹏,钞蕴昕,杨贞,王庆旭,郑爱玲,朱宁.眶内脉管瘤1例[J].山东大学耳鼻喉眼学报,2009,23(6):29-30. 被引量:1
-
3张晓光,徐勇,张志宏,权昌益,马宝杰,张淑敏.新辅助化疗治疗浸润性膀胱癌1例[J].中国肿瘤临床,2008,35(6):331-331. 被引量:2
-
4从排便透视癌症信号[J].医药与保健,2013(7):23-23.
-
5马志龙,张路遥,陈羽佳,徐越超,石未未,所剑.回盲部脉管瘤导致肠套叠1例分析[J].医学与哲学(B),2015,36(3):69-70. 被引量:8
-
6方铣华,陈波,吴梅娟.食管肉瘤样癌[J].河南肿瘤学杂志,2002,15(4):237-239. 被引量:11
-
7王爱英,张毛讲.格拉司琼预防化疗所致恶心呕吐效果观察[J].中原医刊,2007,34(2):85-85. 被引量:1
-
8季加孚.结直肠癌的WHO新分类对外科治疗的意义[J].中国实用外科杂志,2005,25(5):277-277. 被引量:1
-
9张彤,侯宁.食管粘膜癌的临床病理研究[J].实用癌症杂志,2000,15(2):162-163. 被引量:1
-
10畅继武,马腾骧,张淑敏,隋志芳,张新,姚庆祥,孙光,董克权,王文成,王锦,刘淑贤.膀胱移行上皮癌发生发展的分子病理学研究[J].中华泌尿外科杂志,1994,15(6):405-408. 被引量:6